The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases
Open accessAbstract
Histone deacetylase 8 (HDAC8), a unique class I zinc-dependent HDAC, is an emerging target in cancer and other diseases. Its substrate repertoire extends beyond histones to many nonhistone proteins. Besides being a deacetylase, HDAC8 also mediates signaling via scaffolding functions. Aberrant expression or deregulated interactions with transcription factors are critical in HDAC8-dependent cancers. Many potent HDAC8-selective inhibitors with cellular activity and anticancer effects have been reported. We present HDAC8 as a druggable target and discuss inhibitors of different chemical scaffolds with cellular effects. Furthermore, we review HDAC8 activators that revert activity of mutant enzymes. Isotype-selective HDAC8 targeting in patients with HDAC8-relevant cancers is challenging, however, is promising to avoid adverse side effects as observed with pan-HDAC inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Histone deacetylase 8 expression in normal and tumor cells. R2 MegaSampler [66] with HDAC8 probe 223345_at. (A) HDAC8 expression of normal B cells (N1-2, blue), leukocytes (N3, blue) and expression in AML (1-8, green) and ALL (1-5, orange). (B) Normal (blue) colon (N1) expression compared with expression in colon cancer (T Colon 1-15, red). (C) Normal neural crest (N1, blue) expression compared with expression in neuroblastoma (1-4). (D) Normal neural crest (N1, blue) expression compared with expression in neuroblastoma INSS stage 4 and stage 4s samples of the Versteeg (1), Delattre (2), Hiyama (3) and Latowska (4) cohort. ALL: Acute lymphocytic leukemia; AML: Acute myeloid leukemia; HDAC8: Histone deacetylase 8.](https://figures.cochat.ai/paper-figures/e4cf4484a2ed428fa009973f11b9c76a/targeting-histone-deacetylase-8-as-a-therapeutic-approach-to-cancer-and-figure-2.png)







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“an HDAC isozyme that has been shown to be overexpressed in several cancers 19-21”
From Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants (2018) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Chao, M., Chu, P., Chuang, H.-C., Shen, F.-H., Chou, C.-C., Hsu, E., Himmel, L. E., Huang, H.-L., Tu, H., Kulp, S. K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6427 · Cited by 32
RetractedWang, Y., Xu, P., Yao, J., Yang, R., Shi, Z., Zhu, X., Feng, X., & Gao, S. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0390-9 · Cited by 18
RetractedLysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Haberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Seto, E., & Yoshida, M. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018713 · Cited by 1,989
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
Gregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456
HDAC family: What are the cancer relevant targets?
Witt, O., Deubzer, H. E., Milde, T., & Oehme, I. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.08.016 · Cited by 1,069
Self-citationKelly, W. K., O'Connor, O. A., Krug, L. M., Chiao, J. H., Heaney, M., Curley, T., MacGregore-Cortelli, B., Tong, W., Secrist, J. P., Schwartz, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.167 · Cited by 905
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
Targeted therapies: a new generation of cancer treatments.
Gerber, D. E. (2008) · PubMed · Cited by 638
Vannini, A., Volpari, C., Filocamo, G., Casavola, E. C., Brunetti, M., Renzoni, D., Chakravarty, P., Paolini, C., De Francesco, R., Gallinari, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404603101 · Cited by 638
HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
Deardorff, M. A., Bando, M., Nakato, R., Watrin, E., Itoh, T., Minamino, M., Saitoh, K., Komata, M., Katou, Y., Clark, D., et al. (2012) · Nature · doi:10.1038/nature11316 · Cited by 577
Deardorff, M. A., Kaur, M., Yaeger, D., Rampuria, A., Korolev, S., Pie, J., Gil-Rodríguez, C., Arnedo, M., Loeys, B., Kline, A. D., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511888 · Cited by 510
CoREST is an integral component of the CoREST- human histone deacetylase complex
You, A., Tong, J. K., Grozinger, C. M., & Schreiber, S. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1454 · Cited by 502
Gelmetti, V., Zhang, J., Fanelli, M., Minucci, S., Pelicci, P. G., & Lazar, M. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7185 · Cited by 491
Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4
Schilham, M. W., Oosterwegel, M. A., Moerer, P., Ya, J., de Boer, P. A. J., van de Wetering, M., Verbeek, S., Lamers, W. H., Kruisbeek, A. M., Cumano, A., et al. (1996) · Nature · doi:10.1038/380711a0 · Cited by 475
Balasubramanian, S., Ramos, J., Luo, W., Sirisawad, M., Verner, E., & Buggy, J. J. (2008) · Leukemia · doi:10.1038/leu.2008.9 · Cited by 458
Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
Atadja, P. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.019 · Cited by 419
Bradbury, C. A., Khanim, F. L., Hayden, R., Bunce, C. M., White, D. A., Drayson, M. T., Craddock, C., & Turner, B. M. (2005) · Leukemia · doi:10.1038/sj.leu.2403910 · Cited by 404
Histone deacetylase 8 in neuroblastoma tumorigenesis
Oehme, I., Deubzer, H. E., Wegener, D., Pickert, D., Linke, J.-P., Hero, B., Kopp-Schneider, A., Westermann, F., Ulrich, S. M., von Deimling, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0684 · Cited by 398
Self-citationShi, Y., Dong, M., Hong, X., Zhang, W., Feng, J., Zhu, J., Yu, L., Ke, X., Huang, H., Shen, Z., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv237 · Cited by 385
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Lobera, M., Madauss, K. P., Pohlhaus, D. T., Wright, Q. G., Trocha, M., Schmidt, D. R., Baloglu, E., Trump, R. P., Head, M. S., Hofmann, G. A., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1223 · Cited by 376
Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases
Hu, E., Dul, E., Sung, C.-M., Chen, Z., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Liu, R., Lago, A., Hofmann, G., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055541 · Cited by 347
Expression profile of class I histone deacetylases in human cancer tissues
Nakagawa, M., Oda, Y., Eguchi, T., Aishima, S.-I., Yao, T., Hosoi, F., Basaki, Y., Ono, M., Kuwano, M., Tanaka, M., et al. (2007) · Oncology Reports · doi:10.3892/or.18.4.769 · Cited by 341
The establishment of neuronal properties is controlled by Sox4 and Sox11
Bergsland, M., Werme, M., Malewicz, M., Perlmann, T., & Muhr, J. (2006) · Genes & Development · doi:10.1101/gad.403406 · Cited by 339
Hu, E., Chen, Z., Fredrickson, T., Zhu, Y., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Sung, C.-M., Liu, R., & Winkler, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908988199 · Cited by 309
HDAC8: a multifaceted target for therapeutic interventions
Chakrabarti, A., Oehme, I., Witt, O., Oliveira, G., Sippl, W., Romier, C., Pierce, R. J., & Jung, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.013 · Cited by 284
Self-citationAcetylation site specificities of lysine deacetylase inhibitors in human cells
Schölz, C., Weinert, B. T., Wagner, S. A., Beli, P., Miyake, Y., Qi, J., Jensen, L. J., Streicher, W., McCarthy, A. R., Westwood, N. J., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3130 · Cited by 275
Closing the cohesin ring: Structure and function of its Smc3-kleisin interface
Gligoris, T. G., Scheinost, J. C., Bürmann, F., Petela, N., Chan, K.-L., Uluocak, P., Beckouët, F., Gruber, S., Nasmyth, K., & Löwe, J. (2014) · Science · doi:10.1126/science.1256917 · Cited by 268
Vannini, A., Volpari, C., Gallinari, P., Jones, P., Mattu, M., Carfí, A., De Francesco, R., Steinkühler, C., & Di Marco, S. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7401047 · Cited by 256
Boyle, M. I., Jespersgaard, C., Brøndum‐Nielsen, K., Bisgaard, A. ‐., & Tümer, Z. (2015) · Clinical Genetics · doi:10.1111/cge.12499 · Cited by 229
Histone deacetylase 10 promotes autophagy-mediated cell survival
Oehme, I., Linke, J.-P., Böck, B. C., Milde, T., Lodrini, M., Hartenstein, B., Wiegand, I., Eckert, C., Roth, W., Kool, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300113110 · Cited by 221
Self-citationEpigenetic control of skull morphogenesis by histone deacetylase 8
Haberland, M., Mokalled, M. H., Montgomery, R. L., & Olson, E. N. (2009) · Genes & Development · doi:10.1101/gad.1809209 · Cited by 219
Handbook of Experimental Pharmacology
Leng, G., Dickson, S. L., Menzies, J. R. W., Skibicka, K. P., & Egecioglu, K. (2012) · Cited by 217
Osada, H., Tatematsu, Y., Saito, H., Yatabe, Y., Mitsudomi, T., & Takahashi, T. (2004) · International Journal of Cancer · doi:10.1002/ijc.20395 · Cited by 213
Cloning and characterization of a novel human histone deacetylase, HDAC8
BUGGY, J. J., SIDERIS, M. L., MAK, P., LORIMER, D. D., MCINTOSH, B., & CLARK, J. M. (2000) · Biochemical Journal · doi:10.1042/bj3500199 · Cited by 197
Waltregny, D., Glénisson, W., Tran, S. L., North, B. J., Verdin, E., Colige, A., & Castronovo, V. (2005) · The FASEB Journal · doi:10.1096/fj.04-2303fje · Cited by 197
Milde, T., Oehme, I., Korshunov, A., Kopp-Schneider, A., Remke, M., Northcott, P., Deubzer, H. E., Lodrini, M., Taylor, M. D., von Deimling, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0395 · Cited by 193
Self-citationDesign and evaluation of ‘Linkerless’ hydroxamic acids as selective HDAC8 inhibitors
KrennHrubec, K., Marshall, B. L., Hedglin, M., Verdin, E., & Ulrich, S. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.064 · Cited by 192
Histone deacetylases: structural determinants of inhibitor selectivity
Micelli, C., & Rastelli, G. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.007 · Cited by 192
An Acetylation Switch Modulates the Transcriptional Activity of Estrogen-Related Receptor α
Wilson, B. J., Tremblay, A. M., Deblois, G., Sylvain-Drolet, G., & Giguère, V. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0441 · Cited by 192
Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer
Park, C. (2011) · Oncology Reports · doi:10.3892/or.2011.1236 · Cited by 183
Rettig, I., Koeneke, E., Trippel, F., Mueller, W. C., Burhenne, J., Kopp-Schneider, A., Fabian, J., Schober, A., Fernekorn, U., von Deimling, A., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.24 · Cited by 180
Self-citationLucio-Eterovic, A. K., Cortez, M. A. A., Valera, E. T., Motta, F., Queiróz, R. G. D. P., Machado, H. R., Carlotti, C. G., Neder, L., Scrideli, C. A., & Tone, L. G. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-243 · Cited by 177
Marek, M., Kannan, S., Hauser, A.-T., Moraes Mourão, M., Caby, S., Cura, V., Stolfa, D. A., Schmidtkunz, K., Lancelot, J., Andrade, L., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003645 · Cited by 173
Self-citationSuzuki, T., Ota, Y., Ri, M., Bando, M., Gotoh, A., Itoh, Y., Tsumoto, H., Tatum, P. R., Mizukami, T., Nakagawa, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300837y · Cited by 165
Whitehead, L., Dobler, M. R., Radetich, B., Zhu, Y., Atadja, P. W., Claiborne, T., Grob, J. E., McRiner, A., Pancost, M. R., Patnaik, A., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.030 · Cited by 164
Kaiser, F. J., Ansari, M., Braunholz, D., Gil‐Rodríguez, M. C., Decroos, C., Wilde, J. J., Fincher, C. T., Kaur, M., Bando, M., Amor, D. J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu002 · Cited by 164
Durst, K. L., Lutterbach, B., Kummalue, T., Friedman, A. D., & Hiebert, S. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.607-619.2003 · Cited by 161
Rufini, A., Agostini, M., Grespi, F., Tomasini, R., Sayan, B. S., Niklison-Chirou, M. V., Conforti, F., Velletri, T., Mastino, A., Mak, T. W., et al. (2011) · Genes & Cancer · doi:10.1177/1947601911408890 · Cited by 154
Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
Yan, W., Liu, S., Xu, E., Zhang, J., Zhang, Y., Chen, X., & Chen, X. (2013) · Oncogene · doi:10.1038/onc.2012.81 · Cited by 153
A Proton-Shuttle Reaction Mechanism for Histone Deacetylase 8 and the Catalytic Role of Metal Ions
Wu, R., Wang, S., Zhou, N., Cao, Z., & Zhang, Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103932d · Cited by 153
Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A
Lee, H., Rezai-Zadeh, N., & Seto, E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.765-773.2004 · Cited by 153
Waltregny, D., de Leval, L., Glénisson, W., Tran, S. L., North, B. J., Bellahcène, A., Weidle, U. H., Verdin, E. M., & Castronovo, V. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63320-2 · Cited by 145
Cloning and characterization of human histone deacetylase 8
Van den Wyngaert, I., de Vries, W., Kremer, A., Neefs, J.-M., Verhasselt, P., Luyten, W. H. M. L., & Kass, S. U. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01813-5 · Cited by 143
Qian, Y., Zhang, J., Yan, B., & Chen, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708624200 · Cited by 141
Nusinzon, I., & Horvath, C. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3106-3113.2006 · Cited by 140
Tian, Y., Wong, V. W., Wong, G. L., Yang, W., Sun, H., Shen, J., TONG, J. H. M., Go, M. Y. Y., Cheung, Y. S., Lai, P. B. S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3786 · Cited by 138
Hos1 Deacetylates Smc3 to Close the Cohesin Acetylation Cycle
Borges, V., Lehane, C., Lopez‐Serra, L., Flynn, H. R., Skehel, M. J., Ben-Shahar, T. R., & Uhlmann, F. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.009 · Cited by 131
Wagner, F. F., Olson, D. E., Gale, J. P., Kaya, T., Weïwer, M., Aidoud, N., Thomas, M., Davoine, E. L., Lemercier, B. C., Zhang, Y., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301355j · Cited by 129
Heimburg, T., Chakrabarti, A., Lancelot, J., Marek, M., Melesina, J., Hauser, A.-T., Shaik, T. B., Duclaud, S., Robaa, D., Erdmann, F., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01478 · Cited by 124
Self-citationQi, J., Singh, S., Hua, W.-K., Cai, Q., Chao, S.-W., Li, L., Liu, H., Ho, Y., McDonald, T., Lin, A., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.08.004 · Cited by 122
Sequential requirement of Sox4 and Sox11 during development of the sympathetic nervous system
Potzner, M. R., Tsarovina, K., Binder, E., Penzo‐Méndez, A., Lefebvre, V., Rohrer, H., Wegner, M., & Sock, E. (2010) · Development · doi:10.1242/dev.042101 · Cited by 121
Investigating the Selectivity of Metalloenzyme Inhibitors
Day, J. A., & Cohen, S. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401053m · Cited by 109
Wu, R., Lu, Z., Cao, Z., & Zhang, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja111104p · Cited by 108
Wu, J., Du, C., Lv, Z., Ding, C., Cheng, J., Xie, H., Zhou, L., & Zheng, S. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2867-7 · Cited by 108
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
Lodrini, M., Oehme, I., Schroeder, C., Milde, T., Schier, M. C., Kopp‐Schneider, A., Schulte, J. H., Fischer, M., Preter, K. D., Pattyn, F., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt346 · Cited by 105
Self-citationDiscovery of histone deacetylase 8 selective inhibitors
Tang, W., Luo, T., Greenberg, E. F., Bradner, J. E., & Schreiber, S. L. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.134 · Cited by 98
Discovery of the First Histone Deacetylase 6/8 Dual Inhibitors
Olson, D. E., Wagner, F. F., Kaya, T., Gale, J. P., Aidoud, N., Davoine, E. L., Lazzaro, F., Weïwer, M., Zhang, Y., & Holson, E. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400390r · Cited by 98
Synthesis and Biological Evaluation of JAHAs: Ferrocene-Based Histone Deacetylase Inhibitors
Spencer, J., Amin, J., Wang, M., Packham, G., Alwi, S. S. S., Tizzard, G. J., Coles, S. J., Paranal, R. M., Bradner, J. E., & Heightman, T. D. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100295v · Cited by 97
HDAC8 substrates: Histones and beyond
Wolfson, N. A., Pitcairn, C. A., & Fierke, C. A. (2012) · Biopolymers · doi:10.1002/bip.22135 · Cited by 94
Gao, S., Chen, C., Wang, L., Hong, L., Wu, J., Dong, P., & Yu, F. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.10.012 · Cited by 94
p73: A Multifunctional Protein in Neurobiology
Killick, R., Niklison-Chirou, M. V., Tomasini, R., Bano, D., Rufini, A., Grespi, F., Velletri, T., Tucci, P., Sayan, B. S., Conforti, F., et al. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8172-6 · Cited by 90
An Unbiased Approach To Identify Endogenous Substrates of “Histone” Deacetylase 8
Olson, D. E., Udeshi, N. D., Wolfson, N. A., Pitcairn, C. A., Sullivan, E. D., Jaffe, J. D., Svinkina, T., Natoli, T. E., Lü, X., Paulk, J., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500492r · Cited by 89
Lee, H., Sengupta, N., Villagra, A., Rezai‐Zadeh, N., & Seto, E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01971-05 · Cited by 89
HDAC8 and STAT3 repress BMF gene activity in colon cancer cells
Kang, Y., Nian, H., Rajendran, P., Kim, E., Dashwood, W. M., Pinto, J. T., Boardman, L. A., Thibodeau, S. N., Limburg, P. J., Löhr, C. V., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.422 · Cited by 87
Targeting of HDAC8 and investigational inhibitors in neuroblastoma
Oehme, I., Deubzer, H. E., Lodrini, M., Milde, T., & Witt, O. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/14728220903241658 · Cited by 85
Self-citationHistone deacetylase 8 is required for centrosome cohesion and influenza A virus entry
Yamauchi, Y., Boukari, H., Banerjee, I., Sbalzarini, I. F., Horvath, P., & Helenius, A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002316 · Cited by 84
Fu, Y., Zhang, P., Ge, J., Cheng, J., Dong, W., Yuan, H., Du, Y., Yang, M., Sun, R., & Jiang, H. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.07.003 · Cited by 83
Inactivation of CREB mediated gene transcription by HDAC8 bound protein phosphatase
Gao, J., Siddoway, B. A., Huang, Q., & Xia, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.135 · Cited by 81
Koeneke, E., Witt, O., & Oehme, I. (2015) · Cells · doi:10.3390/cells4020135 · Cited by 80
Self-citationHuang, W., Wang, Y., Chao, S.-W., Yang, C., Chen, L., Lin, M., Hou, W., Chen, M., Lee, T., Yang, P., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200300 · Cited by 80
Harakaľová, M., van den Boogaard, M. H., Sinke, R. J., van Lieshout, S., van Tuil, M. C., Duran, K. J., Renkens, I., Terhal, P. A., de Kovel, C. G. F., Nijman, I. J., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-100921 · Cited by 79
Waltregny, D., North, B. J., Mellaert, F. V., de Leval, J., Verdin, E. M., & CASTRONOVO, V. (2004) · PubMed · doi:10.4081/897 · Cited by 77
Nian, H., Bisson, W. H., Dashwood, W. M., Pinto, J. T., & Dashwood, R. H. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp147 · Cited by 77
Kim, I. A., Shin, J. H., Kim, I. H., Kim, J. H., Js, K., Wu, H. G., Chie, E. K., Ha, S. W., Park, C. I., & Kao, G. D. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1230 · Cited by 76
Stolfa, D. A., Marek, M., Lancelot, J., Hauser, A.-T., Walter, A., Leproult, E., Melesina, J., Rumpf, T., Wurtz, J.-M., Cavarelli, J., et al. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.03.007 · Cited by 75
Self-citationHistone deacetylase 8 regulates cortactin deacetylation and contraction in smooth muscle tissues
Li, J., Chen, S., Cleary, R. A., Wang, R., Gannon, O. J., Seto, E., & Tang, D. D. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00102.2014 · Cited by 73
Suzuki, T., Muto, N., Bando, M., Itoh, Y., Masaki, A., Ri, M., Ota, Y., Nakagawa, H., Iida, S., Shirahige, K., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300414 · Cited by 71
de Leval, L., Waltregny, D., Boniver, J., Young, R. H., Castronovo, V., & Oliva, E. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000188029.63706.31 · Cited by 70
Targeting Histone Deacetylases in Neuroblastoma
Witt, O., Deubzer, H. E., Lodrini, M., Milde, T., & Oehme, I. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315774 · Cited by 70
Self-citationDecroos, C., Bowman, C. M., Moser, J. S., Christianson, K. E., Deardorff, M. A., & Christianson, D. W. (2014) · ACS Chemical Biology · doi:10.1021/cb5003762 · Cited by 67
Buchmueller, K. L., Staples, A. M., Howard, C. M., Horick, S. M., Uthe, P. B., Le, N. M., Cox, K., Nguyen, B., Pacheco, K. A. O., Wilson, W. D., et al. (2004) · Journal of the American Chemical Society · doi:10.1021/ja044359p · Cited by 67
Mutant cohesin affects RNA polymerase II regulation in Cornelia de Lange syndrome
Mannini, L., Lamaze, F. C., Cucco, F., Amato, C., Quarantotti, V., Rizzo, I. M., Krantz, I. D., Bilodeau, S., & Musio, A. (2015) · Scientific Reports · doi:10.1038/srep16803 · Cited by 67
Kannan, S., Melesina, J., Hauser, A., Chakrabarti, A., Heimburg, T., Schmidtkunz, K., Walter, A., Marek, M., Pierce, R. J., Romier, C., et al. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci5004653 · Cited by 64
Self-citationHiguchi, T., Nakayama, T., Arao, T., Nishio, K., & Yoshie, O. (2013) · Blood · doi:10.1182/blood-2012-07-441022 · Cited by 63
Azetidinones as Zinc‐Binding Groups to Design Selective HDAC8 Inhibitors
Galletti, P., Quintavalla, A., Ventrici, C., Giannini, G., Cabri, W., Penco, S., Gallo, G., Vincenti, S., & Giacomini, D. (2009) · ChemMedChem · doi:10.1002/cmdc.200900309 · Cited by 63
Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
Tang, G., Wong, J. C., Zhang, W., Wang, Z., Zhang, N., Peng, Z., Zhang, Z., Rong, Y., Li, S., Zhang, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008962 · Cited by 62
Lopez, G., Bill, K. L. J., Bid, H. K., Braggio, D., Constantino, D., Prudner, B., Zewdu, A., Batte, K., Lev, D., & Pollock, R. E. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133302 · Cited by 60
The Activity of HDAC8 Depends on Local and Distal Sequences of Its Peptide Substrates
Gurard‐Levin, Z. A., & Mrksich, M. (2008) · Biochemistry · doi:10.1021/bi800053v · Cited by 60
NMR Profiling of Histone Deacetylase and Acetyl-transferase Activities in Real Time
Dose, A., Liokatis, S., Theillet, F., Selenko, P., & Schwarzer, D. (2011) · ACS Chemical Biology · doi:10.1021/cb1003866 · Cited by 56
Acetylation of Heat Shock Protein 20 (Hsp20) Regulates Human Myometrial Activity
Karolczak‐Bayatti, M., Sweeney, M., Cheng, J., Edey, L. F., Robson, S. C., Ulrich, S. M., Treumann, A., Taggart, M. J., & Europe‐Finner, G. N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.278549 · Cited by 55
Wu, S., Luo, Z., Yu, P. Y., Xie, H., & He, Y. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0215 · Cited by 55
Structure-Based Identification of HDAC8 Non-histone Substrates
Alam, N., Zimmerman, L., Wolfson, N. A., Joseph, C. G., Fierke, C. A., & Schueler‐Furman, O. (2016) · Structure · doi:10.1016/j.str.2016.02.002 · Cited by 52
Melesina, J., Robaa, D., Pierce, R. J., Romier, C., & Sippl, W. (2015) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2015.10.006 · Cited by 51
Self-citationGupta, S. P. (2015) · Chemical Reviews · doi:10.1021/cr500483r · Cited by 49
Song, S., Wang, Y., Xu, P., Yang, R., Ma, Z., Liang, S., & Zhang, G. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3182 · Cited by 48
Decroos, C., Christianson, N., Gullett, L. E., Bowman, C. M., Christianson, K. E., Deardorff, M. A., & Christianson, D. W. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00881 · Cited by 47
Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer
Hsieh, C.-L., Ma, H.-P., Su, C.-M., Chang, Y.-J., Hung, W.-Y., Ho, Y.-S., Huang, W.-J., & Lin, R.-K. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.092 · Cited by 47
Guida, N., Laudati, G., Galgani, M., Santopaolo, M., Montuori, P., Triassi, M., Di Renzo, G., Canzoniero, L. M. T., & Formisano, L. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.07.014 · Cited by 46
Wilmott, J. S., Colebatch, A. J., Kakavand, H., Shang, P., Carlino, M. S., Thompson, J. F., Long, G. V., Scolyer, R. A., & Hersey, P. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.34 · Cited by 45
Giannini, G., Marzi, M., Pezzi, R., Brunetti, T., Battistuzzi, G., Marzo, M. D., Cabri, W., Vesci, L., & Pisano, C. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.029 · Cited by 41
Loop Interactions and Dynamics Tune the Enzymatic Activity of the Human Histone Deacetylase 8
Kunze, M. B. A., Wright, D. W., Werbeck, N. D., Kirkpatrick, J., Coveney, P. V., & Hansen, D. F. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408184x · Cited by 41
Saha, A., Pandian, G. N., Sato, S., Taniguchi, J., Hashiya, K., Bando, T., & Sugiyama, H. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.002 · Cited by 39
Ha, S.-D., Han, C. Y., Reid, C., & Kim, S. O. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400420 · Cited by 36
DEC1 Coordinates with HDAC8 to Differentially Regulate TAp73 and ΔNp73 Expression
Qian, Y., Zhang, J., Jung, Y.-S., & Chen, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084015 · Cited by 36
Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment
Lehmann, M., Hoffmann, M. J., Koch, A., Ulrich, S. M., Schulz, W. A., & Niegisch, G. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0059-8 · Cited by 34
Synthesis of benzothiophene-based hydroxamic acids as potent and selective HDAC6 inhibitors
Vreese, R. D., Steen, N. V., Verhaeghe, T., Desmet, T., Bougarne, N., Bosscher, K. D., Benoy, V., Haeck, W., Bosch, L. V. D., & D’hooghe, M. (2015) · Chemical Communications · doi:10.1039/c5cc03295d · Cited by 33
Singh, P., Mandal, T., Balsubramanian, N., Viaene, T., Leedahl, T. S., Sule, N., Cook, G. R., & Srivastava, D. K. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.080 · Cited by 31
Singh, P., Cho, K., Padi, S. K. R., Yu, J., Haldar, M., Mandal, T., Yan, C., Cook, G. R., Guo, B., Mallik, S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.600627 · Cited by 25
Cao, G. P., Arooj, M., Thangapandian, S., Park, C., Arulalapperumal, V., Kim, Y., Kwon, Y. J., Kim, H. H., Suh, J.-K., & Lee, K. W. (2015) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2015.1040453 · Cited by 22
Kim, J. H., Moon, S. H., No, M., Kim, J. J., Choi, E. J., Cho, B. J., Js, K., Kim, I. H., & Kim, I. A. (2015) · Cancer Research and Treatment · doi:10.4143/crt.2015.206 · Cited by 13
Azetidinone–retinoid hybrids: Synthesis and differentiative effects
Pori, M., Galletti, P., Soldati, R., Calzà, L., Mangano, C., & Giacomini, D. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.09.057 · Cited by 11
MOLECULAR MODELING OF THE INTERACTIONS BETWEEN HISTONE DEACETYLASE 8 AND INHIBITORS
Huang, D., Li, X., & Xiu, Z. (2012) · Journal of Theoretical and Computational Chemistry · doi:10.1142/s0219633612500617 · Cited by 9
Singh, P., ., P., Yadav, B., & Komath, S. S. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.093 · Cited by 8
Effects of trichostatin A on HDAC8 expression, proliferation and cell cycle of Molt-4 cells
He, J., Liu, H., & Chen, Y. (2006) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-006-0511-x · Cited by 7
Cited by
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms
Dadashpour, S., & Emami, S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.065 · Cited by 343
Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy
Liu, T., Wan, Y., Xiao, Y., Xia, C., & Duan, G. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00491 · Cited by 186
Next-generation of selective histone deacetylase inhibitors
Yang, F., Zhao, N., Ge, D., & Chen, Y. (2019) · RSC Advances · doi:10.1039/c9ra02985k · Cited by 154
Marek, M., Shaik, T. B., Heimburg, T., Chakrabarti, A., Lancelot, J., Ramos-Morales, E., Da Veiga, C., Kalinin, D., Melesina, J., Robaa, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01087 · Cited by 122
Self-citationStrategies To Design Selective Histone Deacetylase Inhibitors
Melesina, J., Simoben, C. V., Praetorius, L., Bülbül, E. F., Robaa, D., & Sippl, W. (2021) · ChemMedChem · doi:10.1002/cmdc.202000934 · Cited by 118
Self-citation
Metadata
- Authors
- Chakrabarti, A., Melesina, J., Kolbinger, F. R., Oehme, I., Senger, J., Witt, O., Sippl, W., & Jung, M.
- Affiliations
- University of Freiburg (DE)
- Martin Luther University Halle-Wittenberg (DE)
- German Cancer Research Center (DE)
- Venue
- Future Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2016-08-30
- Volume
- 8
- Issue
- 13
- Pages
- 1609-1634
- ISSN
- 1756-8919 (ISSN-L)
- 1756-8927
- OpenAlex
- W2510695850
- Cited by
- 111
- References
- 127
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 12 · 2023: 8 · 2022: 14 · 2021: 8 · 2020: 15 · 2019: 14 · 2018: 14 · 2017: 9
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Future Medicinal Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Funders
- H.W. & J Hector foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- HDAC8, HDAC8 inhibitors, class I HDACs, transcription factor interaction, cancer therapy, neurodegenerative diseases
- MeSH terms
- Antineoplastic Agents, Histone Deacetylases, Humans, Neoplasms, Repressor Proteins, Neuroprotective Agents, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.